NCT07019389

Brief Summary

This study aims to evaluate the psychometric properties of the Turkish adaptation of the Scale of Food Allergy Anxiety (SOFAA), including both the child-report and parent-report versions. The SOFAA is a validated tool originally developed to assess the specific anxiety related to food allergies. The Turkish versions of the scales will undergo a comprehensive validation process, including assessments of internal consistency, test-retest reliability, and construct validity. Participants will include children diagnosed with IgE-mediated food allergies and their primary caregivers. The study will investigate whether the translated scales maintain the original structure and effectively measure food allergy-related anxiety in the Turkish pediatric population. The findings are expected to contribute to clinical assessment practices and research on food allergy-related psychosocial impacts in Turkeyy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jul 2023Jan 2027

Study Start

First participant enrolled

July 13, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 4, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

June 24, 2025

Status Verified

June 1, 2025

Enrollment Period

3.6 years

First QC Date

June 4, 2025

Last Update Submit

June 18, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Internal Consistency of the Turkish Version of the SOFAA-C and SOFAA-P

    Internal consistency of the Turkish child- and parent-reported versions of the Scale of Food Allergy Anxiety (SOFAA) will be evaluated using Cronbach's alpha coefficient. A value of ≥ 0.70 will be considered acceptable.

    Within 1 week of initial administration

  • Construct Validity of the Turkish Version of SOFAA

    Construct validity of the Turkish version of the SOFAA will be assessed using exploratory and/or confirmatory factor analysis based on responses from children and parents. Factor structure will be compared with the original version.

    Within 1 week of initial administration

  • Test-Retest Reliability of the Turkish Version of SOFAA

    A subsample of participants will complete the SOFAA again after a 10-14 day interval. Test-retest reliability will be evaluated using intraclass correlation coefficient (ICC).

    Approximately 10-14 days after baseline assessment

Study Arms (2)

Children with Food Allergy

Children aged 8 to 18 years diagnosed with IgE-mediated food allergy, recruited from pediatric allergy clinics. Participants complete the Turkish-translated child version of the Scale of Food Allergy Anxiety (SOFAA-C).

Other: Turkish Version of the Scale of Food Allergy Anxiety (SOFAA)

Parents of Children with Food Allergy

Parents or primary caregivers of the participating children complete the parent version of the Turkish-translated Scale of Food Allergy Anxiety (SOFAA-P)

Other: Turkish Version of the Scale of Food Allergy Anxiety (SOFAA)

Interventions

Participants will complete the Turkish-translated versions of the Scale of Food Allergy Anxiety (SOFAA). Children will complete the SOFAA-C; their parents will complete the SOFAA-P. The study aims to evaluate the reliability and validity of the translated scales through internal consistency, factor analysis, and test-retest reliability methods.

Children with Food AllergyParents of Children with Food Allergy

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children aged 8-18 with food allergy and their parents, recruited from pediatric allergy outpatient clinics in Turkey.

You may qualify if:

  • Diagnosed with IgE-mediated food allergy
  • At least one parent/caregiver willing to participate
  • Fluent in Turkish

You may not qualify if:

  • Major neurodevelopmental or psychiatric disorders that impair ability to complete scales

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Istanbul, Turkey (Türkiye)

Location

Related Publications (2)

  • Protudjer JLP. Scales of Food Allergy Anxiety (SOFAA): A Novel Tool to Assess Anxiety Among Children with Food Allergy and Their Caregivers. J Allergy Clin Immunol Pract. 2022 Jan;10(1):170-171. doi: 10.1016/j.jaip.2021.10.036. No abstract available.

    PMID: 35000731BACKGROUND
  • Dahlsgaard KK, Wilkey LK, Stites SD, Lewis MO, Spergel JM. Development of the Child- and Parent-Rated Scales of Food Allergy Anxiety (SOFAA). J Allergy Clin Immunol Pract. 2022 Jan;10(1):161-169.e6. doi: 10.1016/j.jaip.2021.06.039. Epub 2021 Jul 12.

    PMID: 34265450BACKGROUND

MeSH Terms

Conditions

Food HypersensitivityHypersensitivityPhobic DisordersCaregiver BurdenAnxiety Disorders

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateImmune System DiseasesMental DisordersStress, PsychologicalBehavioral SymptomsBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Clinical Fellow in Pediatric Allergy and Immunology

Study Record Dates

First Submitted

June 4, 2025

First Posted

June 13, 2025

Study Start

July 13, 2023

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

January 30, 2027

Last Updated

June 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Only aggregate results (e.g., internal consistency coefficients, summary statistics) will be shared. Individual participant data (IPD), even in de-identified form, will not be made publicly available. Access to data may be considered upon reasonable request and with appropriate ethical approvals.

Shared Documents
CSR
Time Frame
Aggregate data will be available beginning 6 months after study completion and for a period of up to 5 years thereafter.
Access Criteria
Researchers with a methodologically sound proposal may request access to the aggregated study data. Requests should be submitted to the principal investigator and will require appropriate ethical approval and a signed data-sharing agreement.

Locations